ProfileGDS4132 / 226962_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 44% 37% 48% 35% 50% 50% 43% 59% 50% 45% 42% 46% 60% 57% 43% 59% 51% 45% 41% 45% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101114.55344
GSM201543Muscle PCOS pioglitazone 12184.5837
GSM201544Muscle PCOS pioglitazone 161129.73348
GSM201545Muscle PCOS pioglitazone 20197.30135
GSM201829Muscle PCOS pioglitazone 231143.45450
GSM201830Muscle PCOS pioglitazon 251138.08150
GSM201831Muscle PCOS pioglitazone 271111.79743
GSM201832Muscle PCOS pioglitazone 31159.1759
GSM201833Muscle PCOS pioglitazone 41123.75250
GSM201834Muscle PCOS pioglitazone 81115.00845
GSM201835Muscle PCOS after pioglitazone 10294.729242
GSM201836Muscle PCOS after pioglitazone 122111.45846
GSM201837Muscle PCOS after pioglitazone 162148.90460
GSM201838Muscle PCOS after pioglitazone 202149.02157
GSM201839Muscle PCOS after pioglitazone 232104.37243
GSM201840Muscle PCOS after pioglitazone 252162.4559
GSM201841Muscle PCOS after pioglitazone 272119.8851
GSM201842Muscle PCOS after pioglitazone 3298.524845
GSM201843Muscle PCOS after pioglitazone 42103.55741
GSM201844Muscle PCOS after pioglitazone 82114.47545